Literature DB >> 17568785

Chronic kidney disease as a global public health problem: approaches and initiatives - a position statement from Kidney Disease Improving Global Outcomes.

A S Levey1, R Atkins, J Coresh, E P Cohen, A J Collins, K-U Eckardt, M E Nahas, B L Jaber, M Jadoul, A Levin, N R Powe, J Rossert, D C Wheeler, N Lameire, G Eknoyan.   

Abstract

Chronic kidney disease (CKD) is increasingly recognized as a global public health problem. There is now convincing evidence that CKD can be detected using simple laboratory tests, and that treatment can prevent or delay complications of decreased kidney function, slow the progression of kidney disease, and reduce the risk of cardiovascular disease (CVD). Translating these advances to simple and applicable public health measures must be adopted as a goal worldwide. Understanding the relationship between CKD and other chronic diseases is important to developing a public health policy to improve outcomes. The 2004 Kidney Disease Improving Global Outcomes (KDIGO) Controversies Conference on 'Definition and Classification of Chronic Kidney Disease' represented an important endorsement of the Kidney Disease Outcome Quality Initiative definition and classification of CKD by the international community. The 2006 KDIGO Controversies Conference on CKD was convened to consider six major topics: (1) CKD classification, (2) CKD screening and surveillance, (3) public policy for CKD, (4) CVD and CVD risk factors as risk factors for development and progression of CKD, (5) association of CKD with chronic infections, and (6) association of CKD with cancer. This report contains the recommendations from the meeting. It has been reviewed by the conference participants and approved as position statement by the KDIGO Board of Directors. KDIGO will work in collaboration with international and national public health organizations to facilitate implementation of these recommendations.

Entities:  

Mesh:

Year:  2007        PMID: 17568785     DOI: 10.1038/sj.ki.5002343

Source DB:  PubMed          Journal:  Kidney Int        ISSN: 0085-2538            Impact factor:   10.612


  455 in total

1.  Periostin: novel tissue and urinary biomarker of progressive renal injury induces a coordinated mesenchymal phenotype in tubular cells.

Authors:  Bancha Satirapoj; Ying Wang; Mina P Chamberlin; Tiane Dai; Janine LaPage; Lynetta Phillips; Cynthia C Nast; Sharon G Adler
Journal:  Nephrol Dial Transplant       Date:  2011-12-13       Impact factor: 5.992

Review 2.  Cardiovascular disease in chronic kidney disease: data from the Kidney Early Evaluation Program (KEEP).

Authors:  Peter A McCullough; Susan Steigerwalt; Kirit Tolia; Shu-Cheng Chen; Suying Li; Keith C Norris; Adam Whaley-Connell
Journal:  Curr Diab Rep       Date:  2011-02       Impact factor: 4.810

3.  Past Decline Versus Current eGFR and Subsequent Mortality Risk.

Authors:  David M J Naimark; Morgan E Grams; Kunihiro Matsushita; Corri Black; Iefke Drion; Caroline S Fox; Lesley A Inker; Areef Ishani; Sun Ha Jee; Akihiko Kitamura; Janice P Lea; Joseph Nally; Carmen Alicia Peralta; Dietrich Rothenbacher; Seungho Ryu; Marcello Tonelli; Hiroshi Yatsuya; Josef Coresh; Ron T Gansevoort; David G Warnock; Mark Woodward; Paul E de Jong
Journal:  J Am Soc Nephrol       Date:  2015-12-11       Impact factor: 10.121

4.  Albumin testing in urine using a smart-phone.

Authors:  Ahmet F Coskun; Richie Nagi; Kayvon Sadeghi; Stephen Phillips; Aydogan Ozcan
Journal:  Lab Chip       Date:  2013-11-07       Impact factor: 6.799

5.  Kidney Health for Everyone Everywhere - From Prevention to Detection and Equitable Access to Care.

Authors:  Philip Kam-Tao Li; Guillermo Garcia-Garcia; Siu-Fai Lui; Sharon Andreoli; Winston Wing-Shing Fung; Anne Hradsky; Latha Kumaraswami; Vassilios Liakopoulos; Ziyoda Rakhimova; Gamal Saadi; Luisa Strani; Ifeoma Ulasi; Kamyar Kalantar-Zadeh
Journal:  Kidney Dis (Basel)       Date:  2020-03-11

6.  A Soft Computing Approach to Kidney Diseases Evaluation.

Authors:  José Neves; M Rosário Martins; João Vilhena; João Neves; Sabino Gomes; António Abelha; José Machado; Henrique Vicente
Journal:  J Med Syst       Date:  2015-08-27       Impact factor: 4.460

7.  Population-based screening for CKD.

Authors:  Neil R Powe; L Ebony Boulware
Journal:  Am J Kidney Dis       Date:  2009-03       Impact factor: 8.860

8.  Public health surveillance of CKD: principles, steps, and challenges.

Authors:  Neil R Powe; Laura Plantinga; Rajiv Saran
Journal:  Am J Kidney Dis       Date:  2009-03       Impact factor: 8.860

9.  Skin microvascular dysfunction as an early cardiovascular marker in primary hyperoxaluria type I.

Authors:  Alexandra Bruel; Justine Bacchetta; Tiphanie Ginhoux; Christelle Rodier-Bonifas; Anne-Laure Sellier-Leclerc; Bérengère Fromy; Pierre Cochat; Dominique Sigaudo-Roussel; Laurence Dubourg
Journal:  Pediatr Nephrol       Date:  2018-10-01       Impact factor: 3.714

10.  Effect of allopurinol on the glomerular filtration rate of children with chronic kidney disease.

Authors:  Fatemeh Ghane Sharbaf; Farahnak Assadi
Journal:  Pediatr Nephrol       Date:  2018-03-16       Impact factor: 3.714

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.